0000899243-18-007078.txt : 20180312
0000899243-18-007078.hdr.sgml : 20180312
20180312160030
ACCESSION NUMBER: 0000899243-18-007078
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180301
FILED AS OF DATE: 20180312
DATE AS OF CHANGE: 20180312
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gibbs Michael Terrence
CENTRAL INDEX KEY: 0001665000
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36571
FILM NUMBER: 18683338
MAIL ADDRESS:
STREET 1: 12 STONEY BROOK RD.
CITY: HOPKINTON
STATE: MA
ZIP: 01748
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: T2 Biosystems, Inc.
CENTRAL INDEX KEY: 0001492674
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 204827488
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 101 HARTWELL AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
BUSINESS PHONE: 781-457-1200
MAIL ADDRESS:
STREET 1: 101 HARTWELL AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-03-01
0
0001492674
T2 Biosystems, Inc.
TTOO
0001665000
Gibbs Michael Terrence
101 HARTWELL AVENUE
LEXINGTON
MA
02421
0
1
0
0
General Counsel
Stock Option (Right to Buy)
5.08
2018-03-01
4
A
0
90000
0.00
A
2028-03-01
Common Stock
90000
90000
D
The stock option vests in 48 equal monthly installments commencing March 1, 2018.
/s/ John Sprague, Attorney-in-fact
2018-03-12